Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 109,240	$ 90,030
Short-term marketable securities (amortized cost of $308,885 and $412,282, respectively)	307,990	408,166
Accounts receivable, net	31,545	40,057
Inventory	18,960	14,453
Prepaid expenses and other current assets	9,074	9,440
Total current assets	476,809	562,146
Long-term assets
Property and equipment, net	79,390	83,447
Operating lease right-of-use assets	77,109	80,763
Restricted cash	2,923	2,398
Intangible assets, net	5,985	6,827
Goodwill	118,972	118,972
Other assets	3,352	2,064
Total assets	764,540	856,617
Current liabilities
Accounts payable	9,163	8,084
Accrued liabilities	8,356	12,424
Accrued compensation and benefits	10,554	15,935
Current portion of operating lease liabilities	9,345	9,230
Current portion of deferred revenue	57,917	64,115
Total current liabilities	95,335	109,788
Long-term liabilities
Operating lease liabilities, less current portion	94,176	98,772
Deferred revenue, less current portion	50,895	58,599
Revenue interest liability, net	128,167	125,360
Total liabilities	368,573	392,519
Commitments and contingencies (Note 9)
Shareholders’ equity
Preferred stock: $0.0001 par value, 10,000,000 shares authorized at June 30, 2023 and December 31, 2022; no shares issued and outstanding at June 30, 2023 and December 31, 2022
Common stock: $0.0001 par value, 340,000,000 shares authorized at June 30, 2023 and December 31, 2022; 144,645,118 and 143,105,002 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively	14	14
Additional paid-in capital	1,421,506	1,387,349
Accumulated other comprehensive loss	(893)	(4,116)
Accumulated deficit	(1,024,591)	(919,082)
Total Adaptive Biotechnologies Corporation shareholders’ equity	396,036	464,165
Noncontrolling interest	(69)	(67)
Total shareholders’ equity	395,967	464,098
Total liabilities and shareholders’ equity	$ 764,540	$ 856,617

Revenue interest liability, net

No definition available.

Name:	adpt_RevenueInterestLiabilityNet
Namespace Prefix:	adpt_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).